136 related articles for article (PubMed ID: 21059548)
1. Conservative management of pituitary macroadenoma contacting the optic apparatus.
Ryu WH; Tam S; Rotenberg B; Labib MA; Lee D; Nicolle DA; Van Uum S; Duggal N
Can J Neurol Sci; 2010 Nov; 37(6):837-42. PubMed ID: 21059548
[TBL] [Abstract][Full Text] [Related]
2. Visual Defects in Patients With Pituitary Adenomas: The Myth of Bitemporal Hemianopsia.
Lee IH; Miller NR; Zan E; Tavares F; Blitz AM; Sung H; Yousem DM; Boland MV
AJR Am J Roentgenol; 2015 Nov; 205(5):W512-8. PubMed ID: 26496573
[TBL] [Abstract][Full Text] [Related]
3. The volume of tumor mass and visual field defect in patients with pituitary macroadenoma.
Lee JP; Park IW; Chung YS
Korean J Ophthalmol; 2011 Feb; 25(1):37-41. PubMed ID: 21350693
[TBL] [Abstract][Full Text] [Related]
4. Optic nerve hyperintensity on T2-weighted images among patients with pituitary macroadenoma: correlation with visual impairment.
Tokumaru AM; Sakata I; Terada H; Kosuda S; Nawashiro H; Yoshii M
AJNR Am J Neuroradiol; 2006 Feb; 27(2):250-4. PubMed ID: 16484385
[TBL] [Abstract][Full Text] [Related]
5. [Adenoma of the pituitary gland in the ophthalmologist's out-patient practice].
Kochánová I; Stasek A; Kubena T
Cesk Slov Oftalmol; 2004 Sep; 60(5):348-55. PubMed ID: 15566223
[TBL] [Abstract][Full Text] [Related]
6. Decision Making for Patients With Concomitant Pituitary Macroadenoma and Ophthalmologic Comorbidity: A Clinical Controversy.
Hajiabadi M; Alimohamadi M; Fahlbusch R
World Neurosurg; 2015 Jul; 84(1):147-53. PubMed ID: 25769486
[TBL] [Abstract][Full Text] [Related]
7. Pituitary Macroadenoma and Visual Impairment: Postoperative Outcome Prediction with Contrast-Enhanced FIESTA.
Hisanaga S; Kakeda S; Yamamoto J; Watanabe K; Moriya J; Nagata T; Fujino Y; Kondo H; Nishizawa S; Korogi Y
AJNR Am J Neuroradiol; 2017 Nov; 38(11):2067-2072. PubMed ID: 28912278
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and ophthalmologic findings of pituitary adenoma in Korean patients.
Kim TG; Jin KH; Kang J
Int Ophthalmol; 2019 Jan; 39(1):21-31. PubMed ID: 29274021
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities of scanning laser polarimetry associated with pituitary adenoma.
Tanito M; Itai N; Goto T; Ohira A; Chihara E
Am J Ophthalmol; 2003 Apr; 135(4):565-7. PubMed ID: 12654388
[TBL] [Abstract][Full Text] [Related]
10. The Predictive Value of Suprasellar Extension for Visual Function Evaluation in Chinese Patients with Nonfunctioning Pituitary Adenoma with Optic Chiasm Compression.
Gan L; Ma J; Feng F; Wang Y; Cui J; Guo X; Zhang X; You H; Wang Z; Yin Z; Zhong Y; Xing B
World Neurosurg; 2018 Aug; 116():e960-e967. PubMed ID: 29857216
[TBL] [Abstract][Full Text] [Related]
11. Unusual cause of visual symptoms after bilateral laser in situ keratomileusis.
Sandhu SS; Gnanaraj L; James A; Figueiredo FC
J Cataract Refract Surg; 2005 Feb; 31(2):446-9. PubMed ID: 15767173
[TBL] [Abstract][Full Text] [Related]
12. Clinical features associated with lesions other than pituitary adenoma in patients with an optic chiasmal syndrome.
Mejico LJ; Miller NR; Dong LM
Am J Ophthalmol; 2004 May; 137(5):908-13. PubMed ID: 15126157
[TBL] [Abstract][Full Text] [Related]
13. Edema of the optic tract in patients with tumors of the sellar region: clinical and visual implications in the pediatric population.
Bussat A; Proisy M; Bruneau B; Bouzillé G; Chappé C; Riffaud L
J Neurosurg Pediatr; 2018 May; 21(5):516-522. PubMed ID: 29498601
[TBL] [Abstract][Full Text] [Related]
14. Modern neuro-ophthalmological evaluation of patients with pituitary disorders.
Vié AL; Raverot G
Best Pract Res Clin Endocrinol Metab; 2019 Apr; 33(2):101279. PubMed ID: 31178379
[TBL] [Abstract][Full Text] [Related]
15. Patterns of visual loss associated with pituitary macroadenomas.
Poon A; McNeill P; Harper A; O'Day J
Aust N Z J Ophthalmol; 1995 May; 23(2):107-15. PubMed ID: 7546685
[TBL] [Abstract][Full Text] [Related]
16. Visual disturbances in patients with pituitary adenoma.
Ikeda H; Yoshimoto T
Acta Neurol Scand; 1995 Aug; 92(2):157-60. PubMed ID: 7484065
[TBL] [Abstract][Full Text] [Related]
17. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma.
Dekkers OM; Pereira AM; Roelfsema F; Voormolen JH; Neelis KJ; Schroijen MA; Smit JW; Romijn JA
J Clin Endocrinol Metab; 2006 May; 91(5):1796-801. PubMed ID: 16507632
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of the multi-channel PVEP and PERG in the diagnosis and management of the patient with pituitary adenoma: a case report.
Lachowicz E; Lubiński W
Doc Ophthalmol; 2018 Aug; 137(1):37-45. PubMed ID: 29968203
[TBL] [Abstract][Full Text] [Related]
19. Pituitary Macroadenoma Presenting With Monocular Temporal Hemianopia.
Gupta A; Deshmukh M; Palexas G
J Neuroophthalmol; 2021 Jun; 41(2):e267-e268. PubMed ID: 33136669
[TBL] [Abstract][Full Text] [Related]
20. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma.
Ogra S; Nichols AD; Stylli S; Kaye AH; Savino PJ; Danesh-Meyer HV
J Clin Neurosci; 2014 May; 21(5):735-40. PubMed ID: 24656736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
